However, they are not more likely to experience emotional exhaustion
Cost, finding a provider, and stigma are top barriers to receiving treatment
Highest rates seen among children of non-Hispanic American Indian or Alaska Native individuals
Increased risk for depressive symptoms, diagnoses seen among perimenopausal, but not postmenopausal, women
Caregiver anxiety and neighborhood factors associated with greater symptom burden
Rapid procedure noninferior to standard procedure for successful initiation of extended-release naltrexone
2021 study shows less access to telehealth and worse reported experiences with video visits
Disparities observed for nearly all leading causes of injury and disease associated with recent increases in youth mortality rates
Benefit seen with additional six weeks of treatment after six weeks of initial failure with varenicline or nicotine replacement
Clinician-patient relationship tied to depression symptoms through 12 months









